Aamal Company Q.P.S.C. Through Its Subsidiary Ebn Sina Medical, Announces Its Intention to Commence Negotiations for Potential Acquisition

Aamal Company Q.P.S.C. (“Aamal”), one of the region’s leading diversified companies, announces its intention to commence negotiations, through its subsidiary, Ebn Sina Medical, in relation to a potential acquisition as part of Aamal’s strategy to expand and further diversify its business portfolio.

Aamal’s subsidiary, Ebn Sina Medical, intends to commence negotiations to acquire shares in “Q life Pharma” (Qatar Llhayat Factory W.L.L.), specializing in the manufacture of bags and bottles for medical and sterile intravenous solutions, as well as a range of pharmaceutical products, including tablets, capsules, dry suspensions, syrups, liquid suspensions, ointments, creams, eye drops, suppositories, injectable solutions, and antibiotics.

Click here to download attachment